Dorantes-Acosta E, Zapata-Tarrés M, Miranda-Lora AL, Reyes-López A, Muñoz HO, Cortés-Gallo G, Garduño EJ

Language: Spanish
References: 18
Page: 212-217
PDF size: 426.34 Kb.

ABSTRACT

Background. Cancer is the second leading cause of pediatric mortality. Acute lymphoblastic leukemia (ALL) is the most common type of cancer. In Mexico, families affiliated with the Seguro Popular insurance program have access to medical, pharmaceutical and hospital services that meet their health needs. The objective of the study was to determine the impact of nongovernmental organization (NGO) support on mortality in ALL patients affiliated with the Seguro Popular program.
Methods. We conducted 182 interviews with families with living and deceased patients with ALL in nine institutions affiliated with the Seguro Popular program. We inquired about the expenses necessary during ALL treatment and whether they received support from NGO and the type of support received. We performed bivariate analysis to determine the statistical weight of the support of NGO on crude mortality.
Results. Families of patients with ALL affiliated with the Seguro Popular insurance program incurred additional expenses during treatment. NGO support was statistically significant in protection from mortality (OR = 0.25; 95% CI 0.11–0.54). Significant items were support with food, medicines, antibiotics and catheters.
Conclusions. NGO offer a high level of support for ALL patients and although they are not a substitute for the support of the Popular Insurance Scheme, they provide a holistic type of support and demonstrate a positive effect in reducing mortality.

REFERENCES

1. Tefferi A, Killmann NM. Globalization of treatment strategies in leukemia: challenges and responsibilities. Leukemia 2008;22:1093-1094.

2. Pérez-Zaldívar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, Martínez-Avalos A, Medina-Sansón A, Espinosa-Hernández L, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer 2011;11:355-366. doi:10.1186/1471-2407-11-355

3. Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 2003;290:2008-2014.

4. Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011;29:551-565.

5. Secretaría de Salud. Decreto por el que se reforma y adiciona la Ley General de Salud. Diario Oficial de la Federación. México; 15 de mayo de 2003. Disponible en: http://dof.gob.mx/nota_detalle.php?codigo=695626&fecha=15/05/2003

6. Secretaría de Salud. Reglamento de la Ley General de Salud en Materia de Protección Social en Salud. Diario Oficial de la Federación. México; 5 de abril de 2004. Disponible en: http://dof.gob.mx/nota_detalle.php?codigo=671625&fecha=05/04/2004

7. Secretaría de Salud. Comisión Nacional de Protección en Salud/Seguro Popular. Catálogo Universal de Servicios de Salud (CAUSES) 2010. México; 2010. Disponible en: http://www.seguro-popular.salud.gob.mx/images/contenidos/Causes/catalogo_2010.pdf

8. Fundación Casa de la Amistad para Niños con Cáncer I.A.P. Disponible en: http://www.casadelaamistad.org.mx

9. Fundación Luz de Vida. Disponible en: http://www.luzdevida.org.mx

10. Fundación Aquí Nadie se Rinde. Disponible en: http://www.aquinadieserinde.org.mx/

11. Gulis G, Garrido-Herrero L, Katreniakova Z, Harvey G, McCarthy M, Slovak Public Health Association. Public health research priorities in Europe seen by non-governmental organizations. Cent Eur J Public Health 2008;16:209-212.

12. Morillas JD, Castells A, Oriol I, Pastor A, Pérez-Segura P, Echevarría JM, et al. The Alliance for the Prevention of Colorectal Cancer in Spain. A civil commitment to society. Gastroenterol Hepatol 2012;35:109-128.

13. Alberti KG, Bailey CJ, Blonde L, Felton AM, Zimmet P, Global Partnership for Effective Diabetes Management. Partnering with governments and other institutions: driving change in diabetes care. Int J Clin Pract Suppl 2007;157:38-46.

14. Allen CF, Simon Y, Edwards J, Simeon DT. Adherence to antiretroviral therapy by people accessing services from nongovernmental HIV support organizations in three Caribbean countries. West Indian Med J 2011;60:269-275.

15. Narayanan S, Vicknasingam B, Robson NM. The transition to harm reduction: understanding the role of non-governmental organizations in Malaysia. Int J Drug Policy 2011;22:311-317.

16. Tylavsky FA, Smith K, Surprise H, Garland S, Yan X, Mc- Cammon E, et al. Nutritional intake of long-term survivors of childhood acute lymphoblastic leukemia: evidence for bone health interventional opportunities. Pediatr Blood Cancer 2010;55:1362-1369.

17. Dávila-Rodríguez MI, Novelo-Huerta HI, Márquez-Solís R, Cortés-Gutiérrez E, Pérez-Cortés P, Cerda-Flores RM. Nutritional indicators in children with acute lymphoblastic leukemia. Rev Med Inst Mex Seguro Soc 2010;48:639-644.

18. Gupta S, Antillon FA, Bonilla M, Fu L, Howard SC, Ribeiro RC, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011;117:4788-4795. doi: 10.1002/cncr.26107.